Gastrointestinal stromal tumours (GIST): biology and treatment.
Judson
I
I
Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.
D001549:Benzamides; D001707:Biopsy, Needle; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D009367:Neoplasm Staging; D009372:Neoplasms, Connective Tissue / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000473:pathology / Q000628:therapy; D017154:Stromal Cells / Q000473:pathology*; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate